PAVAN REDDY to Hematologic Neoplasms
This is a "connection" page, showing publications PAVAN REDDY has written about Hematologic Neoplasms.
Connection Strength
1.695
-
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease. Blood. 2024 01 04; 143(1):21-31.
Score: 0.678
-
Current and emerging strategies for the prevention of graft-versus-host disease. Nat Rev Clin Oncol. 2014 Sep; 11(9):536-47.
Score: 0.350
-
Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):564-9.
Score: 0.295
-
Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2019 08; 25(8):1682-1688.
Score: 0.121
-
Advances in understanding the pathogenesis of graft-versus-host disease. Br J Haematol. 2016 Apr; 173(2):190-205.
Score: 0.099
-
TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes. Biol Blood Marrow Transplant. 2012 Oct; 18(10):1525-32.
Score: 0.075
-
Extracorporeal photo-chemotherapy for graft-versus-host disease. Haematologica. 2005 Aug; 90(8):1013B.
Score: 0.047
-
Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 02; 25(2):343-353.
Score: 0.029